uterine leiomyosarcoma

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uterine Leiomyosarcoma Trial (Letrozole)

Not yet recruiting
  • Uterine Leiomyosarcoma
  • (no location specified)
Dec 6, 2022

LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)

Suspended
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
Oct 24, 2022

Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma Trial in Canada, United States (saracatinib)

Completed
  • Adult Fibrosarcoma
  • +14 more
  • Rockledge, Pennsylvania
  • +3 more
May 29, 2018

Uterine Leiomyosarcoma, Uterine Cancer Trial in New York (Docetaxel plus Gemcitabine)

Completed
  • Uterine Leiomyosarcoma
  • Uterine Cancer
  • Docetaxel plus Gemcitabine
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 21, 2015

Uterine Leiomyosarcoma Trial (Pazopanib)

Withdrawn
  • Uterine Leiomyosarcoma
  • (no location specified)
Nov 17, 2015

Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Leiomyosarcoma Trial in New York (sorafenib tosylate)

Completed
  • Adult Angiosarcoma
  • +14 more
  • sorafenib tosylate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
May 7, 2014